Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in: World Journal of Surgical Oncology 1/2013

Open Access 01-12-2013 | Research

Visceral fat changes after distal gastrectomy according to type of reconstruction procedure for gastric cancer

Authors: Koji Tanaka, Isao Miyashiro, Masahiko Yano, Kentaro Kishi, Masaaki Motoori, Tatsushi Shingai, Shingo Noura, Masayuki Ohue, Hiroaki Ohigashi, Osamu Ishikawa

Published in: World Journal of Surgical Oncology | Issue 1/2013

Login to get access

Abstract

Background

Noncancerous causes of death, such as cerebrovascular or cardiac disease, are not rare in patients with gastric cancer who had undergone curative gastrectomy. Metabolic syndrome, characterized by visceral fat accumulation, is a risk factor for cerebrovascular and cardiac diseases. However, there is limited information on the effects of reconstruction procedures on changes in visceral fat after distal gastrectomy. The aim of this study was to analyze the impact of the reconstruction procedure (Roux-en-Y reconstruction (RY) and Billroth I reconstruction (BI)) on changes in visceral fat, as determined using computed tomography.

Methods

The study subjects were 152 patients with gastric cancer who underwent distal gastrectomy with lymphadenectomy between 2002 and 2007. The visceral fat area was measured for one cross-sectional computed tomogram obtained at the level of the umbilicus.

Results

Adjuvant chemotherapy (yes vs. no, P = 0.0006), type of reconstruction (BI vs. RY, P = 0.0146), field of lymph node dissection (<D2 vs. ≥D2, P = 0.0020), omentectomy (yes vs. no, P = 0.0003), and pathological stage (1/2 vs. 3/4; P = 0.0023) correlated significantly with postoperative visceral fat loss. Multivariate logistic regression analysis identified reconstruction (BI vs. RY; P = 0.0232) and adjuvant chemotherapy (yes vs. no, P = 0.0330) as the significant determinants of visceral fat loss after surgery.

Conclusions

Visceral fat loss after RY was larger than that after BI. Further prospective studies are needed to confirm the effects of reconstruction after distal gastrectomy on visceral fat.
Appendix
Available only for authorised users
Literature
1.
Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, Katai H, Tsujitani S, Kodera Y, Seto Y, Kaminishi M: Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011, 14: 301-316. 10.1007/s10120-011-0085-6.PubMedCentralCrossRefPubMed
2.
Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, Nagahori Y, Hosoi H, Takahashi M, Kito F, Shimada H: Significance of long-term follow-up of early gastric cancer. Ann Surg Oncol. 2006, 13: 363-369. 10.1245/ASO.2006.03.061.CrossRefPubMed
3.
Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S: Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987, 36: 54-59. 10.1016/0026-0495(87)90063-1.CrossRefPubMed
4.
Fujimoto WY, Newell-Morris LL, Grote M, Bergstrom RW, Shuman WP: Visceral fat obesity and morbidity: NIDDM and atherogenic risk in Japanese American men and women. Int J Obes. 1991, 15 (Suppl 2): 41-44.PubMed
5.
Marcus MA, Murphy L, Pi-Sunyer FX, Albu JB: Insulin sensitivity and serum triglyceride level in obese white and black women: relationship to visceral and truncal subcutaneous fat. Metabolism. 1999, 48: 194-199. 10.1016/S0026-0495(99)90033-1.CrossRefPubMed
6.
Lee SE, Lee JH, Ryu KW, Nam B, Kim CG, Park SR, Kook MC, Kim YW: Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer. Hepatogastroenterology. 2012, 59: 430-435.CrossRefPubMed
7.
Moriwaki Y, Kunisaki C, Kobayashi S, Harada H, Imai S, Kasaoka C: Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy?. Hepatogastroenterology. 2003, 50: 284-288.PubMed
8.
Armbrecht U, Lundell L, Lindstedt G, Stockbruegger RW: Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand. 1988, 154: 37-41.PubMed
9.
Bradley EL, Isaacs J, Hersh T, Davidson ED, Millikan W: Nutritional consequences of total gastrectomy. Ann Surg. 1975, 182: 415-429. 10.1097/00000658-197510000-00007.PubMedCentralCrossRefPubMed
10.
Friess H, Bohm J, Muller MW, Glasbrenner B, Riepl RL, Malfertheiner P, Buchler MW: Maldigestion after total gastrectomy is associated with pancreatic insufficiency. Am J Gastroenterol. 1996, 91: 341-347.PubMed
11.
Adams JF: The clinical and metabolic consequences of total gastrectomy. I. Morbidity, weight, and nutrition. Scand J Gastroenterol. 1967, 2: 137-149. 10.3109/00365526709180059.CrossRefPubMed
12.
Liedman B, Andersson H, Bosaeus I, Hugosson I, Lundell L: Changes in body composition after gastrectomy: results of a controlled, prospective clinical trial. World J Surg. 1997, 21: 416-420. 10.1007/PL00012264. Discussion 420–421CrossRefPubMed
13.
Kiyama T, Mizutani T, Okuda T, Fujita I, Tokunaga A, Tajiri T, Barbul A: Postoperative changes in body composition after gastrectomy. J Gastrointest Surg. 2005, 9: 313-319. 10.1016/j.gassur.2004.11.008.CrossRefPubMed
14.
Japanese Gastric Cancer A: Japanese Classification of Gastric Carcinoma - 2nd English edition. Gastric Cancer. 1998, 1: 10-24.CrossRef
15.
Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S, Matsuzawa Y: Abdominal fat: standardized technique for measurement at CT. Radiology. 1999, 211: 283-286.CrossRefPubMed
16.
Miyato H, Kitayama J, Hidemura A, Ishigami H, Kaisaki S, Nagawa H: Vagus nerve preservation selectively restores visceral fat volume in patients with early gastric cancer who underwent gastrectomy. J Surg Res. 2012, 173: 60-67. 10.1016/j.jss.2010.08.040.CrossRefPubMed
17.
Yoon DY, Kim HK, Kim JA, Choi CS, Yun EJ, Chang SK, Lee YJ, Park CH: Changes in the abdominal fat distribution after gastrectomy: computed tomography assessment. ANZ J Surg. 2007, 77: 121-125. 10.1111/j.1445-2197.2006.03990.x.CrossRefPubMed
18.
Olbers T, Bjorkman S, Lindroos A, Maleckas A, Lonn L, Sjostrom L, Lonroth H: Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg. 2006, 244: 715-722. 10.1097/01.sla.0000218085.25902.f8.PubMedCentralCrossRefPubMed
19.
Falko JM, Crockett SE, Cataland S, Mazzaferri EL: Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. J Clin Endocrinol Metab. 1975, 41: 260-265. 10.1210/jcem-41-2-260.CrossRefPubMed
20.
Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y: Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med. 2002, 8: 738-742. 10.1038/nm727.CrossRefPubMed
21.
Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ: Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007, 3: 597-601. 10.1016/j.soard.2007.08.004.PubMedCentralCrossRefPubMed
22.
Jendle J, Nauck MA, Matthews DR, Frid A, Hermansen K, During M, Zdravkovic M, Strauss BJ, Garber AJ: Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue. Diabetes Obes Metab. 2009, 11: 1163-1172. 10.1111/j.1463-1326.2009.01158.x.CrossRefPubMed
23.
Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, Kern B, von Fluee M, Beglinger C: Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012, 22: 740-748. 10.1007/s11695-012-0622-3.PubMedCentralCrossRefPubMed
24.
Takase M, Sumiyama Y, Nagao J: Quantitative evaluation of reconstruction methods after gastrectomy using a new type of examination: digestion and absorption test with stable isotope 13C-labeled lipid compound. Gastric Cancer. 2003, 6: 134-141. 10.1007/s10120-003-0238-3.CrossRefPubMed
25.
Fabbrini E, Tamboli RA, Magkos F, Marks-Shulman PA, Eckhauser AW, Richards WO, Klein S, Abumrad NN: Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults. Gastroenterology. 2010, 139: 448-455. 10.1053/j.gastro.2010.04.056.PubMedCentralCrossRefPubMed
26.
Dillard TH, Purnell JQ, Smith MD, Raum W, Hong D, Laut J, Patterson EJ: Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial. Surg Obes Relat Dis. 2013, 9: 269-275. 10.1016/j.soard.2011.09.027.CrossRefPubMed
Metadata
Title
Visceral fat changes after distal gastrectomy according to type of reconstruction procedure for gastric cancer
Authors
Koji Tanaka
Isao Miyashiro
Masahiko Yano
Kentaro Kishi
Masaaki Motoori
Tatsushi Shingai
Shingo Noura
Masayuki Ohue
Hiroaki Ohigashi
Osamu Ishikawa
Publication date
01-12-2013
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2013
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-11-146

Other articles of this Issue 1/2013

World Journal of Surgical Oncology 1/2013 Go to the issue

Case report

Combined large cell neuroendocrine carcinoma with giant cell carcinoma of the lungs: a case report

Research

Video-assisted thoracoscopic surgery versus robotic-assisted thoracoscopic surgery in the surgical treatment of Masaoka stage I thymoma

Technical innovations

Spinal metastasis from malignant meningeal intracranial hemangiopericytoma: one-staged percutaneous Onyx™ embolization and resection - a technical innovation

Research

Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy

Research

Fast access and early ligation of the renal pedicle significantly facilitates retroperitoneal laparoscopic radical nephrectomy procedures: modified laparoscopic radical nephrectomy

Research

Surgical decompression improves recovery from neurological deficit and may provide a survival benefit in patients with diffuse large B-cell lymphoma-associated spinal cord compression: a case-series study